GALDERMA LABS LP FDA Approval NDA 021415

NDA 021415

GALDERMA LABS LP

FDA Drug Application

Application #021415

Documents

Letter2005-06-07
Label2005-06-07
Review2006-03-21
Letter2004-07-30
Letter2008-06-30
Letter2012-11-23
Label2004-07-30
Label2008-06-30
Label2012-11-28

Application Sponsors

NDA 021415GALDERMA LABS LP

Marketing Status

Discontinued001

Application Products

001CREAM;TOPICALEQ 16.8% BASE0METVIXIAMETHYL AMINOLEVULINATE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2004-07-27STANDARD
EFFICACY; EfficacySUPPL3AP2008-06-26STANDARD
LABELING; LabelingSUPPL4AP2012-11-20STANDARD

Submissions Property Types

ORIG1Null0
SUPPL3Null0
SUPPL4Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21415
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.